MIRAGEN THERAPEUTICS INC's ticker is MGEN and the CUSIP is 60463E103. A total of 28 filers reported holding MIRAGEN THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $10,000 | -28.6% | 12,400 | 0.0% | 0.00% | – |
| Q2 2020 | $14,000 | +133.3% | 12,400 | 0.0% | 0.00% | – |
| Q1 2020 | $6,000 | 0.0% | 12,400 | 0.0% | 0.00% | – |
| Q4 2019 | $6,000 | -33.3% | 12,400 | 0.0% | 0.00% | – |
| Q3 2019 | $9,000 | -64.0% | 12,400 | 0.0% | 0.00% | – |
| Q2 2019 | $25,000 | -97.7% | 12,400 | -96.8% | 0.00% | – |
| Q1 2019 | $1,069,000 | -2.2% | 383,297 | +6.2% | 0.00% | – |
| Q4 2018 | $1,093,000 | -47.5% | 360,766 | -3.2% | 0.00% | – |
| Q3 2018 | $2,081,000 | +6.3% | 372,647 | +21.9% | 0.00% | – |
| Q2 2018 | $1,958,000 | +67.8% | 305,768 | +84.0% | 0.00% | – |
| Q1 2018 | $1,167,000 | -26.5% | 166,145 | +9.0% | 0.00% | – |
| Q4 2017 | $1,587,000 | +49.7% | 152,383 | +31.5% | 0.00% | – |
| Q3 2017 | $1,060,000 | -22.7% | 115,921 | +9.3% | 0.00% | – |
| Q2 2017 | $1,372,000 | – | 106,045 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 3,142,580 | $1,414,000 | 1.91% |
| Game Plan Financial Advisors, LLC | 44,550 | $17,000 | 0.02% |
| Alyeska Investment Group, L.P. | 743,398 | $332,000 | 0.01% |
| Alyeska Investment Group, L.P. | 500,000 | $223,000 | 0.00% |
| Aveo Capital Partners, LLC | 16,732 | $7,000 | 0.00% |
| Squarepoint Ops LLC | 67,258 | $30,000 | 0.00% |
| MERCER GLOBAL ADVISORS INC /ADV | 13,121 | $6,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 2,261 | $1,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 51,297 | $23,000 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 154 | $69,000 | 0.00% |